Skip to Main Content
Services Talent Knowledge
Site Search
Menu

PressRelease

April 3, 2023

Xun Chen Joins Barclay Damon

Barclay Damon Announces Xun Chen, associate, has joined Barclay Damon’s Commercial Litigation and Torts & Products Liability Defense Practice Areas. Her primary office is New York City.

Chen focuses her practice on complex commercial litigation in state and federal courts. She represents corporate and individual clients across a variety of industries, including consumer products, industrial products, pharmaceuticals, automotive, and aviation, in products liability cases, class actions, securities litigation, and contract disputes. Her representation has included Fortune 100 and 500 companies in multi-million dollar lawsuits.

Prior to joining Barclay Damon, Chen was an associate at a firm in New York City. She also gained experience as a summer associate at a firm in New York City and as a law clerk with the New York State Office of the Attorney General.

Barclay Damon attorneys team across offices and practices to provide customized, targeted solutions grounded in industry knowledge and a deep understanding of our clients’ businesses. With nearly 300 attorneys, Barclay Damon is a leading law firm that operates from a strategic platform of offices located in the Northeastern United States and Toronto. For more information, visit our award-winning website at barclaydamon.com.
 

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Featured Media

Alerts

DOL's Proposed Defined Contribution Plan Investment Rule Could Give Fiduciaries More Room to Consider Alternatives

Alerts

NYSDEC Freshwater Wetland Regulations Struck Down

Alerts

Proposed Changes to NYISO Deliverability Could Cut Upstate Transmission Upgrade Costs by Nearly $1 Billion

Alerts

Amendment to the New York Trapped at Work Act Provides Employers With Clarity and Time to Comply

Alerts

New York's Medical Aid in Dying Act: What Patients and Health Care Providers Need to Know

Alerts

Second Department Holds That COVID-Era Executive Orders Toll CVA Revival Window